切换至 "中华医学电子期刊资源库"

中华疝和腹壁外科杂志(电子版) ›› 2022, Vol. 16 ›› Issue (05) : 595 -599. doi: 10.3877/cma.j.issn.1674-392X.2022.05.023

临床病例分析

腹壁子宫内膜异位症相关性透明细胞癌一例及文献回顾
杨泽成1, 史常赛1, 陈佳乐1, 李金龙1,()   
  1. 1. 130041 长春,吉林大学第二医院胃肠营养外科
  • 收稿日期:2022-03-25 出版日期:2022-10-18
  • 通信作者: 李金龙

Endometriosis-associated clear cell carcinoma of the abdominal wall: a case report and review of the literature

Zecheng Yang1, Changsai Shi1, Jiale Chen1, Jinlong Li1,()   

  1. 1. Department of Gastrointestinal Surgery, the Second Hospital of Jilin University, Changchun 130041, China
  • Received:2022-03-25 Published:2022-10-18
  • Corresponding author: Jinlong Li
引用本文:

杨泽成, 史常赛, 陈佳乐, 李金龙. 腹壁子宫内膜异位症相关性透明细胞癌一例及文献回顾[J/OL]. 中华疝和腹壁外科杂志(电子版), 2022, 16(05): 595-599.

Zecheng Yang, Changsai Shi, Jiale Chen, Jinlong Li. Endometriosis-associated clear cell carcinoma of the abdominal wall: a case report and review of the literature[J/OL]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2022, 16(05): 595-599.

目的

探讨剖宫产术后腹壁子宫内膜异位症(AWE)相关性透明细胞癌(CCC)的临床特点、治疗方法和预防措施。

方法

搜集近10年AWE后恶性病变的相关资料结合1例相关患者的诊疗过程,对资料进行系统回顾分析。

结果

共检索出410篇文献,最终25篇(其中英文20篇,中文5篇)文献符合纳入标准,纳入31例剖宫产后AWE发生CCC患者。其中12例行单纯肿瘤切除,17例同时行肿瘤切除和附加手术,2例未行手术治疗。接受化疗的患者为21例,放疗者6例,同时接受放化疗者5例。2例接受了术前新辅助化疗。12例患者出现肿瘤的扩散或转移。23例有随访信息,随访期间死于疾病者4例,带病存活者8例,无疾病迹象者11例。本文报道1例AWE后发生CCC的患者,行病灶及部分腹壁切除后使用补片进行腹壁重建治疗,术后恢复良好。

结论

AWE后发生CCC恶变的情况近几年有增加的趋势。目前对此类恶变过程缺乏有效的预防与观察手段,对AWE者应早期行病变切除手术。对发生恶变者,应行包括病灶在内的腹壁整块切除手术,形成的缺损可行包括应用补片的腹壁重建手术治疗。

Objective

To investigate the clinical features, treatment and prevention of clear cell carcinoma (CCC) associated with abdominal wall endometriosis (AWE) after cesarean section.

Methods

The data of malignant degeneration after AWE in the past 10 years were collected and analyzed systematically, combined with the diagnosis and treatment process of one patient.

Results

A total of 410 articles were retrieved, and finally 25 articles (including 20 English articles and 5 Chinese articles) met the inclusion criteria, of which 31 patients with AWE after cesarean section were diagnosed with CCC. Among them, 12 cases underwent simple tumor resection, 17 cases underwent tumor resection and additional surgery, and 2 cases did not undergo surgery. Twenty-one patients received chemotherapy, 6 patients received radiotherapy, 5 patients received both radiotherapy and chemotherapy, and 2 patients received preoperative neoadjuvant chemotherapy. Twelve patients had tumor spread or metastasis. Twenty-three patients had follow-up information. During the follow-up period, 4 patients died of the disease, 8 patients survived with the disease, and 11 patients had no signs of the disease. This paper reports a case of CCC after AWE. After resection of the lesion and part of the abdominal wall, the abdominal wall reconstruction with mesh was performed, and the postoperative recovery was good.

Conclusion

The incidence of CCC malignant transformation after AWE has increased in recent years. At present, there is a lack of effective prevention and observation methods for this malignant transformation process. Early lesion resection should be performed for patients with AWE. For those with malignant transformation, en bloc resection of the abdominal wall including the lesion should be performed, and the formed defect can be treated by abdominal wall reconstruction with mesh.

表1 检索文献纳入31例腹壁子宫内膜异位症相关性透明细胞癌患者资料
病例 年龄(岁) 是否转移/扩散 手术方式 大体病理性质 化疗/放疗 随访时间(月) 随访时情况 作者
1 41 LR 囊性 是/否 24 无疾病迹象 Yan等[1]
2 42 LR,TAH,BSO,OMT 卡铂+紫杉醇/否 26 无疾病迹象 Mert等[2]
3 51 LR,BSO,OMT 否/是 49 无疾病迹象 Mert等[2]
4 47 LR 纤维性 顺铂/是 7 无疾病迹象 Shalin等[3]
5 41 LR 囊性 卡铂+紫杉醇/— Sawazaki等[4]
6 49 LR 囊实混合 卡铂+紫杉醇/否 8 无疾病迹象 Li等[5]
7 39 LR,TAH,BSO,OMT 卡铂+紫杉醇/否 12 因病死亡 Liu等[6]
8 37 LR —/— 5 带病生存 Heller等[7]
9 42 LR —/—   无疾病迹象 Dobrosz等[8]
10 60 LR 囊实混合 否/否 8 带病生存 Ijichi等[9]
11 47 LR,TAH,BSO,OMT 卡铂+紫杉醇/否 10 无疾病迹象 Aust等[10]
12 41 LR 囊性 卡铂+紫杉醇/是 6 带病生存 Ruiz等[11]
13 57 LR,TAH,BSO 卡铂+紫杉醇/是 Ruiz等[11]
14 44 NACT, LR,TAH,BSO 囊实混合 否/否 6 因病死亡 Ferrandina等[12]
15 46 LR 囊实混合 否/否 Wei等[13]
16 58 LR,TAH 否/否 6 带病生存 Ewa等[14]
17 47 LR,BSO 囊性 卡铂+紫杉醇/否 9 带病生存 Marques等[15]
18 42 LR,TAH,BSO 囊性 是/否 2 无疾病迹象 Gentile等[16]
19 40 LR,TAH,BSO,OMT,BPLND 囊性 铂类+紫杉醇/— 12 带病生存 张承等[17]
20 52 LR,TAH,BSO 囊性 否/否 14 带病生存 Lai等[18]
21 56 LR,TAH,BSO,OMT,BPLND 囊性 卡铂+紫杉醇/否 11 无疾病迹象 Lai等[18]
22 56 LR,TAH,BSO,BPLND 囊性 卡铂+紫杉醇/否 5 无疾病迹象 Lai等[18]
23 55 TAH,BSO, NACT,OMT 囊性 吉西他滨+卡铂+贝伐单抗/否 23 因病死亡 Lai等[18]
24 45 未手术 囊性 卡铂+紫杉醇;脂质体阿霉素+卡铂/是 7 带病生存 Lai等[18]
25 48 LR,TAH,BSO,OMT 囊实混合 卡铂+紫杉醇/否 4 无疾病迹象 Lopes等[19]
26 48 LR 囊实混合 否/否 2 Ronlon等[20]
27 55 LR,TAH,BSO 囊实混合 洛铂+紫杉醇/否 崔莹莹等[21]
28 54 LR,TAH,BSO,OMT 囊性 铂类+紫杉醇/否 曾美龄等[22]
29 47 LR 囊性 卡铂+紫杉醇/否 曾昊等[23]
30 49 未手术 实性 卡铂+紫杉醇;吉西他滨;阿霉素/是 7 因病死亡 GIANNELLA等[24]
31 41 LR 囊实混合 —/— 唐庄艳等[25]
图3 术中应用补片行腹壁重建
图4 术后镜下病理图像
[1]
Yan Y, Li L, Guo J, et al. Malignant transformation of an endometriotic lesion derived from an abdominal wall scar[J]. Int J Gynaecol Obstet, 2011, 115(2): 202-203.
[2]
Mert I, Semaan A, Kim S, et al. Clear cell carcinoma arising in the abdominal wall: two case reports and literature review[J]. Am J Obstet Gynecol, 2012, 207(2): e7-9.
[3]
Shalin SC, Haws AL, Carter DG, et al. Clear cell adenocarcinoma arising from endometriosis in abdominal wall cesarean section scar: a case report and review of the literature[J]. J Cutan Pathol, 2012, 39(11): 1035-1041.
[4]
Sawazaki H, Goto H, Takao N, et al. Clear cell adenocarcinoma arising from abdominal wall endometriosis mimicking urachal tumor[J]. Urology, 2012, 79(6): e84-85.
[5]
Li X, Yang J, Cao D, et al. Clear-cell carcinoma of the abdominal wall after cesarean delivery[J]. Obstet Gynecol, 2012, 120(2 Pt 2): 445-448.
[6]
Liu H, Leng J, Lang J, et al. Clear cell carcinoma arising from abdominal wall endometriosis: a unique case with bladder and lymph node metastasis[J]. World J Surg Oncol, 2014, 12: 2-7.
[7]
Heller DS, Houck K, Lee ES, et al. Clear cell adenocarcinoma of the abdominal wall: a case report[J]. J Reprod Med, 2014, 59(5/6): 330-332.
[8]
Dobrosz Z, Paleń P, Stojko R, et al. Clear cell carcinoma derived from an endometriosis focus in a scar after a caesarean section-a case report and literature review[J]. Ginekol Pol, 2014, 85(10): 792-795.
[9]
Ijichi S, Mori T, Suganuma I, et al. Clear cell carcinoma arising from cesarean section scar endometriosis: case report and review of the literature[J]. Case Rep Obstet Gynecol, 2014, 2014: 642483.
[10]
Aust S, Tiringer D, Grimm C, et al. Therapy of a clear cell adenocarcinoma of unknown primary arising in the abdominal wall after cesarean section and after hysterectomy[J]. Wien Klin Wochenschr, 2015, 127(1/2): 62-64.
[11]
Ruiz MP, Wallace DL, Connell MT. Transformation of Abdominal Wall Endometriosis to Clear Cell Carcinoma[J]. Case Rep Obstet Gynecol, 2015, 2015: 123740.
[12]
Ferrandina G, Palluzzi E, Fanfani F, et al. Endometriosis-associated clear cell carcinoma arising in caesarean section scar: a case report and review of the literature[J]. World J Surg Oncol, 2016, 14(1): 300.
[13]
Wei C J, Huang S H. Clear cell carcinoma arising from scar endometriosis: A case report and literature review[J]. Ci Ji Yi Xue Za Zhi, 2017, 29(1): 55-58.
[14]
Ewa K, Marianna B, Mateusz W, et al. Clear Cell Carcinoma of the abdominal wall[J]. Pol Prz Chir Polish J Surg, 2017, 89: 40-43.
[15]
Marques C, Silva TS, Dias MF. Clear cell carcinoma arising from abdominal wall endometriosis-Brief report and review of the literature[J]. Gynecol Oncol Rep, 2017, 20: 78-80.
[16]
Gentile J K A, Migliore R, Kistenmacker F J N, et al. Malignant transformation of abdominal wall endometriosis to clear cell carcinoma: case report[J]. Sao Paulo Med J, 2018, 136(6): 586-590.
[17]
张承,赵昊云,钱敏, 等. 腹壁切口子宫内膜异位症恶变为透明细胞癌一例[J]. 中华妇产科杂志, 2018, 53(12): 869.
[18]
Lai Y L, Hsu H C, Kuo K T, et al. Clear Cell Carcinoma of the Abdominal Wall as a Rare Complication of General Obstetric and Gynecologic Surgeries: 15 Years of Experience at a Large Academic Institution[J]. Int J Environ Res Public Health, 2019, 16(4): 552.
[19]
Lopes A, Anton C, Slomovitz BM, et al. Clear cell carcinoma arising from abdominal wall endometrioma after cesarean section[J]. Int J Gynecol Cancer, 2019, 29(8): 1332-1335.
[20]
Rivera Rolon M D M, Allen D, Richardson G, et al. Abdominal Wall Clear Cell Carcinoma: Case Report of a Rare Event with Potential Diagnostic Difficulties[J]. Case Rep Pathol, 2019, 2019: 1695734.
[21]
崔莹莹,闫莉,荣风年. 腹壁透明细胞癌1例[J]. 山东大学学报(医学版), 2019, 57(12): 118-120.
[22]
曾美龄. 腹壁透明细胞癌:病例报告与文献讨论[J]. 妇癌医学期刊, 2020, 52: 11-15.
[23]
曾昊,林汇斯,廖洁婕, 等. 腹壁剖宫产瘢痕子宫内膜异位症恶变为透明细胞癌1例[J]. 广西医科大学学报, 2021, 38(9): 1829-1831.
[24]
Giannella L, Serri M, Maccaroni E, et al. Endometriosis-associated Clear Cell Carcinoma of the Abdominal Wall After Caesarean Section: A Case Report and Review of the Literature[J]. In Vivo, 2020, 34(4): 2147-2152.
[25]
唐庄艳,孔乔俊,王立岩, 等. 剖宫产术后腹壁瘢痕子宫内膜异位症癌变1例[J]. 中国实验诊断学, 2020, 24(5): 859-860.
[26]
Wyrens R, Randall L. Endometriosis in scars[J]. Am J Surg, 1942, 56: 397-403.
[27]
Ji W, Wu J, Cheng J, et al. Serous adenocarcinoma arising from endometriosis in cesarean section abdominal wall scar: a case report and literature review[J]. Int J Clin Exp Pathol, 2017, 10(7): 7534-7541.
[28]
Mihailovici A, Rottenstreich M, Kovel S, et al. Endometriosis-associated malignant transformation in abdominal surgical scar: A PRISMA-compliant systematic review[J]. Medicine(Baltimore), 2017, 96(49): e9136.
[29]
Soleymani majd H, Ismail L, Hardern K, et al. Comparison of survival outcome of patients with primary peritoneal and fallopian tube carcinoma treated with neoadjuvant chemotherapy versus primary debulking surgery[J]. Obstet Gynaecol(Lahore), 2017, 37(1): 89-92.
[30]
Tozzi R, Giannice R, Cianci S, et al. Neo-adjuvant chemotherapy does not increase the rate of complete resection and does not significantly reduce the morbidity of Visceral-Peritoneal Debulking(VPD) in patients with stage ⅢC-Ⅳ ovarian cancer[J]. Gynecol Oncol, 2015, 138(2): 252-258.
[31]
HONG S C, KHOO C K. An update on adenomyosis uteri[J]. Gynecology and Minimally Invasive Therapy, 2016, 5: 106-810.
[1] 刘柏隆, 周祥福. 经阴道膀胱膨出前盆补片修补术 + 阴道后壁修补术[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 128-128.
[2] 张超, 过菲, 王富博, 叶宸, 杨悦, 杨波. 腹腔镜肾部分切除术:肾癌合并肾静脉癌栓的新选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 219-224.
[3] 曹能琦, 张恒, 郑立锋, 陶庆松, 嵇振岭. Ad-Hoc 自裁剪补片用于造口旁疝Sugarbaker 修补术[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 620-623.
[4] 皮尔地瓦斯·麦麦提玉素甫, 李慧灵, 艾克拜尔·艾力, 李赞林, 王志, 克力木·阿不都热依木. 生物补片修补巨大复发性腹壁切口疝临床疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 624-628.
[5] 顾熙, 徐子宇, 周澍, 张吴楼, 张业鹏, 林昊, 刘宗航, 嵇振岭, 郑立锋. 腹股沟疝腹膜前间隙无张力修补术后补片感染10 例报道[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 665-669.
[6] 臧宇, 姚胜, 朱新勇, 戎世捧, 田智超. 低温等离子射频消融治疗腹壁疝术后补片感染的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 687-692.
[7] 朱佳琳, 方向, 贵诗雨, 黄丹, 周小雨, 郭文恺. 大鼠切口疝腹膜前间隙补片修补术后血清中VEGF 和Ang-1 的表达情况[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 703-707.
[8] 周艳, 李盈, 周小兵, 程发辉, 何恒正. 不同类型补片联合Nissen 胃底折叠术修补食管裂孔疝的疗效及复发潜在危险因素[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 528-533.
[9] 汤福鑫, 黄浩男, 马宁, 周太成, 陈双. 疝补片的发展:从人工补片到智能材料[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 365-368.
[10] 许伟, 曹道成, 孙畅, 马雨九. 不同补片用于腹股沟疝腹腔镜手术中的安全性及对患者功能康复的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 423-427.
[11] 张蕾, 彭超, 周应芳. 直肠阴道隔子宫内膜异位症腹腔镜手术技巧[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 257-261.
[12] 胡启明, 鄢潇, 尤志学, 黄骁昊. 经瘢痕处单孔腹腔镜下切除多病灶腹壁子宫内膜异位症[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 314-317.
[13] 芦煜, 李振宇, 吴承东, 周仲伍. 肛周子宫内膜异位症一例报告[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 431-434.
[14] 胡子豪, 王喆, 陈建海, 齐岩松, 徐永胜. 聚合物材料在肩袖损伤治疗中的研究进展[J/OL]. 中华肩肘外科电子杂志, 2024, 12(04): 362-368.
[15] 洪凡, 陈敦金, 傅洋, 梁新月, 吴毅, 王晓怡. 体外受精-胚胎移植妊娠合并前置胎盘临床研究[J/OL]. 中华产科急救电子杂志, 2024, 13(03): 176-182.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?